Alkem Laboratories Ltd. News and Updates

Name: Latest research reports of Alkem Laboratories Ltd. authored by Dolat Capital and published by - Trendlyne research reports.
Item: Alkem Laboratories Ltd.
Rating: 5
Author: Dolat Capital

Keep track of all breaking news on Alkem Laboratories Ltd. from all sources in a single place.

Load latest

Alkem Laboratories Ltd.

09 Feb 2021

5007.00

1.50%

Buy Alkem Laboratories; target of Rs 3242: Dolat Capital Market

Moneycontrol

Dolat Capital Market is bullish on Alkem Laboratories has recommended buy rating on the stock with a target price of Rs 3242 in its research report dated February 07, 2021.

Number of FII/FPI investors increased from 524 to 535 in Mar 2025 qtr.

Alkem Laboratories Ltd.

10 Nov 2020

5007.00

1.50%

Buy Alkem Laboraties; target of Rs 3570: Motilal Oswal

Moneycontrol

Motilal Oswal is bullish on Alkem Laboraties recommended buy rating on the stock with a target price of Rs 3570 in its research report dated November 07, 2020.

Alkem Laboratories Ltd. is trading below its 150 day SMA of 5031.3

Alkem Laboratories Ltd.

07 Nov 2020

5007.00

1.50%

Buy Alkem Laboratories; target of Rs 3290: Dolat Capital Market

Moneycontrol

Dolat Capital Market is bullish on Alkem Laboratories has recommended buy rating on the stock with a target price of Rs 3290 in its research report dated November 07, 2020.

Alkem Laboratories Ltd. is trading below its 150 day SMA of 5031.3

Alkem Laboratories Ltd.

07 Nov 2020

5007.00

1.50%

Alkem Lab

Buy: Alkem Laboratories Ltd.

Target

Dolat Capital

Alkem reported an in-line 2Q driven by exports and speedy recovery in India. Despite an acute heavy portfolio, India formulations were flattish YoY, up 35% QoQ exhibiting a sharp recovery aided by double digit growth in trade generics. US ($84mn) was strong with 12% CC growth backed by new launches and market share gains. As marketing and promotional activities resume slowly in India (~70%), EBITDA margins came 120bps lower sequentially at 25.4%. However, with promotional activities resuming normalcy we expect 2H to report margins of 15-16%,...

Alkem Laboratories Ltd. is trading above its 100 day SMA of 4919.0

Alkem Laboratories Ltd.

06 Nov 2020

5007.00

1.50%

Alkem Laboratories Q2 net profit up 27% to Rs 482 crore

Moneycontrol

The company had posted a net profit of Rs 380.52 crore for the corresponding period of the previous fiscal, Alkem Laboratories said in a BSE filing.

Alkem Laboratories L.. has an average target of 5278.50 from 2 brokers.

Alkem Laboratories Q2 net profit up 27 per cent to Rs 482 cr

Business Line | 06 Nov 2020

Alkem Laboratories Ltd.

12 Oct 2020

5007.00

1.50%

First Light | Monthly Eco Chartbook, Monetary Policy Review

Buy: Alkem Laboratories Ltd.

BOB Capital Markets Ltd.

Monthly Chartbook: Green shoots emerging. Monetary Policy Review: Lender of last resort

Alkem Laboratories Ltd.'s price crossed above 30Day SMA today

Alkem Laboratories Ltd.

22 Sep 2020

5007.00

1.50%

Double-digit sales dip in anti-infective segment to weigh on Alkem Labs

Business Standard

Higher chronic sales, US market could offset some of the weakness in sales growth

Alkem Laboratories Ltd. is trading above its 100 day SMA of 4919.0

Alkem Laboratories Ltd.

11 Aug 2020

5007.00

1.50%

Buy ALKEM Laboraties; target of Rs 3665: Motilal Oswal

Moneycontrol

Motilal Oswal is bullish on ALKEM Laboraties recommended buy rating on the stock with a target price of Rs 3665 in its research report dated August 08, 2020.